
CDC Expands Pathogen Testing at Logan Airport to Prevent Spread of Infectious Diseases
The United States Centers for Disease Control and Prevention (CDC) is expanding its Traveler-based Genomic Surveillance system at Boston's Logan International Airport, as part of a pilot program at four major airports. The program involves voluntary nasal sampling of international travelers to detect flu A/B, RSV, SARS-CoV-2, and other pathogens. Positive samples will be sent to the CDC for analysis. Wastewater from certain flights will also be analyzed. The goal is to detect and prevent the spread of illnesses, providing early critical information to public health officials.
